Which antidepressant has the least anticholinergic side effects?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Antidepressants with Least Anticholinergic Side Effects

Among antidepressants, bupropion, SSRIs (particularly fluoxetine, sertraline, fluvoxamine), and SNRIs (venlafaxine, milnacipran, levomilnacipran, desvenlafaxine) have the least anticholinergic side effects, with bupropion and the SSRIs being the preferred first-line choices for patients where anticholinergic burden is a concern.

Evidence-Based Ranking

Minimal to No Anticholinergic Activity

The most recent pharmacological data identifies specific antidepressants with negligible anticholinergic effects:

  • Bupropion (noradrenaline and dopamine reuptake inhibitor) - shows <35% inhibition of muscarinic receptors 1
  • SSRIs: Fluvoxamine, sertraline, fluoxetine - all demonstrate <35% muscarinic receptor inhibition 1
  • SNRIs: Milnacipran, levomilnacipran, venlafaxine, desvenlafaxine - minimal anticholinergic binding 1
  • Trazodone (5-HT2A blocker) - <35% muscarinic inhibition 1

Moderate Anticholinergic Activity (Avoid if Possible)

  • Paroxetine - while an SSRI, it has notably higher anticholinergic effects than other SSRIs 2
  • Mirtazapine - has potent antihistaminic properties but relatively low anticholinergic effects (note: sedation from mirtazapine is antihistaminic, not anticholinergic) 3

High Anticholinergic Activity (Avoid)

  • Tricyclic antidepressants - particularly amitriptyline (anticholinergic equivalence: 8.99) have the highest anticholinergic burden 3

Clinical Decision Algorithm

When anticholinergic burden is a primary concern (elderly patients, cognitive impairment, Alzheimer's disease, urinary retention, constipation):

  1. First choice: Bupropion or SSRIs (fluoxetine, sertraline, fluvoxamine) 1, 4, 5
  2. Second choice: SNRIs (venlafaxine, milnacipran, levomilnacipran, desvenlafaxine) 1
  3. Avoid: Tricyclic antidepressants and paroxetine

Important Caveats

Distinguishing Sedation from Anticholinergic Effects

A critical pitfall is assuming sedating medications have high anticholinergic activity. Quetiapine and mirtazapine cause sedation through antihistaminic (H1) blockade, not anticholinergic mechanisms 3. This distinction matters because antihistaminic sedation does not carry the same cognitive and peripheral risks as anticholinergic effects.

Guideline Framework

The American College of Physicians guidelines recommend selecting second-generation antidepressants based on adverse effect profiles, as efficacy is equivalent across agents 6. Since anticholinergic effects represent a major adverse effect category, this guideline supports choosing agents with minimal anticholinergic activity when this is a patient-specific concern 6.

Special Populations

For patients with Alzheimer's disease or dementia, the antidepressants with <35% muscarinic receptor inhibition are specifically recommended 1. The cumulative anticholinergic burden from multiple medications is associated with cognitive impairment, falls, and poorer clinical outcomes, particularly in elderly populations 3.

Practical Considerations

  • Fluoxetine and sertraline have been extensively studied and confirmed to have minimal anticholinergic effects compared to tricyclics 4, 5
  • Citalopram (another SSRI) also demonstrates low anticholinergic activity 2
  • The older literature consistently shows SSRIs have significantly fewer anticholinergic effects than tricyclic antidepressants 2, 5

References

4
Research

The side effect profile and safety of fluoxetine.

The Journal of clinical psychiatry, 1985

Related Questions

In a 9‑week‑old infant with subfebrile temperature (maximum 37.8 °C), rhinorrhea, cough, a single post‑cough vomiting episode, inconsolable crying with transient abdominal tenderness that resolves when the infant stops crying, and normal stooling, what is the best management approach?
After percutaneous coronary catheterisation (PCCC), how is the arterial puncture closed?
What is the appropriate treatment for a 25‑year‑old woman with malodorous leukorrhea?
What is the appropriate workup and treatment for a 75-year-old woman with acute swollen fingers limiting movement?
Which anti‑staphylococcal antibiotic is recommended for use in the emergency department for serious infections?
When should spironolactone be used versus finerenone in hypertensive patients, such as those with resistant hypertension or those with type 2 diabetes and chronic kidney disease?
What is the recommended treatment for scabies?
What are the contraindications for tranexamic acid?
In a patient with type 2 diabetes and non‑alcoholic fatty liver disease, which is more beneficial for liver outcomes: a DPP‑4 inhibitor (e.g., sitagliptin) or an SGLT‑2 inhibitor (e.g., empagliflozin or dapagliflozin)?
Should a patient with mumps be isolated?
What is the recommended epinephrine (adrenaline) dose for adults and children in shock?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.